Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:46 UTC |
---|
HMDB ID | HMDB0014886 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Carbinoxamine |
---|
Description | Carbinoxamine is a first generation antihistamine that competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. The product label for carbinoxamine as an over the counter cough and cold medicine is being modified to state 'do not use' in children under 4 years of age in order to prevent and reduce misuse, as many unapproved carbinoxamine-containing preparations contained inappropriate labeling, which promoted unapproved uses (including management of congestion, cough, the common cold, and the use in children under 2 years of age), which can potentially cause serious health risks. |
---|
Structure | CN(C)CCOC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 InChI=1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
(+-)-Carbinoxamine | ChEBI | 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine | ChEBI | Carbinoxamina | ChEBI | Carbinoxamine base | ChEBI | Carbinoxaminum | ChEBI | Paracarbinoxamine | ChEBI | {2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine | ChEBI | 2-(p-Chloro-a-(2-(dimethylamino)ethoxy)benzyl)pyridine | Generator | 2-(p-Chloro-α-(2-(dimethylamino)ethoxy)benzyl)pyridine | Generator | Carbinoxamine maleate | HMDB | Paracarinoxamine | HMDB | Histex PD | HMDB | Histex CT | HMDB | Histex I-e | HMDB |
|
---|
Chemical Formula | C16H19ClN2O |
---|
Average Molecular Weight | 290.788 |
---|
Monoisotopic Molecular Weight | 290.118590947 |
---|
IUPAC Name | {2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]ethyl}dimethylamine |
---|
Traditional Name | carbinoxamine |
---|
CAS Registry Number | 486-16-8 |
---|
SMILES | CN(C)CCOC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 |
---|
InChI Identifier | InChI=1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3 |
---|
InChI Key | OJFSXZCBGQGRNV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzylethers. These are aromatic ethers with the general formula ROCR' (R = alkyl, aryl; R'=benzene). |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzylethers |
---|
Direct Parent | Benzylethers |
---|
Alternative Parents | |
---|
Substituents | - Benzylether
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Pyridine
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Dialkyl ether
- Ether
- Azacycle
- Organoheterocyclic compound
- Organohalogen compound
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organochloride
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | < 25 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.23 g/L | Not Available | LogP | 2.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Carbinoxamine EI-B (Non-derivatized) | splash10-0ab9-9000000000-a413c068c7a879eb2068 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Carbinoxamine EI-B (Non-derivatized) | splash10-0ab9-9000000000-a413c068c7a879eb2068 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Carbinoxamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0pb9-9180000000-b7d95742727b1ef0a3c4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Carbinoxamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0ab9-9200000000-c3abf61d5cdaa81de77d | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Carbinoxamine , positive-QTOF | splash10-0uxr-0490000000-9ece1371a4992f21aa52 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 10V, Positive-QTOF | splash10-0006-1090000000-eecfc1a96c21589df023 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 20V, Positive-QTOF | splash10-006x-4090000000-f55a8c538f446792b084 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 40V, Positive-QTOF | splash10-00di-9210000000-cc26b029a0e987b18446 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 10V, Negative-QTOF | splash10-000i-0090000000-dbe5de39fc21f0c12088 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 20V, Negative-QTOF | splash10-00kr-0190000000-757e5fdc2e3d83027d7a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 40V, Negative-QTOF | splash10-014i-7890000000-70eeab9a0ba6cc4b2449 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 10V, Positive-QTOF | splash10-0f6x-0090000000-8e6319ead8805445ce4f | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 20V, Positive-QTOF | splash10-0udi-0090000000-b1b5900f97954c8ed449 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 40V, Positive-QTOF | splash10-0uk9-5090000000-c844f1f981eb3e25a3bf | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 10V, Negative-QTOF | splash10-000i-0090000000-f8ccd79e440175ba372a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 20V, Negative-QTOF | splash10-0gb9-2190000000-37dda60416c010f365ad | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbinoxamine 40V, Negative-QTOF | splash10-0gb9-4490000000-742d9da4f019f9a49ad2 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00748 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00748 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00748 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB005796 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2466 |
---|
KEGG Compound ID | C06871 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Carbinoxamine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2564 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 3398 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - BEALE HD, RAWLING FF, FIGLEY KD: Clistin maleate; a clinical appraisal of a new antihistaminic. J Allergy. 1954 Nov;25(6):521-4. [PubMed:13211145 ]
|
---|